» Articles » PMID: 35115349

Factors Associated with Recruitment Success in the Phase 2a Study of Aztreonam-avibactam Development Programme: a Descriptive Qualitative Analysis Among Sites in Spain

Abstract

Objective: Successful clinical trials are subject to recruitment. Recently, the REJUVENATE trial, a prospective phase 2a open-label, single-arm interventional clinical trial conducted within the Innovative Medicines Initiative-supported Combatting Bacterial Resistance in Europe-Carbapenem Resistance project, was published, with 85% of the recruitment performed in Spain. We analysed the recruitment success in this trial by establishing a model of recruitment practice.

Methods: A descriptive qualitative study was performed from May 2016 to October 2017 at 10 participating Spanish centres. Data were extracted from: (1) feasibility questionnaires to assess the centre's potential for patient enrolment; (2) delegation of responsibility records; (3) pre-screening records including an anonymised list of potentially eligible and (4) screening and enrolment records. A descriptive analysis of the features was performed by the participating centre. Pearson's and Spearman's correlation coefficients were calculated to determine factors of recruitment success.

Results: The highest recruitment rate was observed in Hospitals 3 and 6 (58.8 and 47.0 patients per month, respectively). All the study teams were multidisciplinary with a median of 15 members (range: 7-22). Only Hospitals 3, 5 and 6 had dedicated nursing staff appointed exclusively to this study. Moreover, in those three hospitals and in Hospital 9, the study coordinator performed exclusive functions as a research planner, and did not assume these functions for the other hospitals. The univariate analysis showed a significant association between recruitment success and months of recruitment (p=0.024), number of staff (p<0.001), higher number of pharmacists (p=0.005), infectious disease specialists (p<0.001), the presence of microbiologist in the research team (p=0.018) and specifically dedicated nursing staff (p=0.036).

Conclusions: The existence of broad multidisciplinary teams with staff dedicated exclusively to the study as well as the implementation of a well-designed local patient assessment strategy were the essential optimisation factors for recruitment success in Spain.

Trial Registration Number: NCT02655419; EudraCT 2015-002726-39; analysis of pre-screened patients.

Citing Articles

"The Truth Is, We Must Miss Some": A Qualitative Study of the Patient Eligibility Screening Process, and Automation Perspectives, for Cancer Clinical Trials.

La Rosa A, Vaterkowski M, Cuggia M, Campillo-Gimenez B, Tournigand C, Baujat B Cancer Med. 2024; 13(23):e70466.

PMID: 39624972 PMC: 11612666. DOI: 10.1002/cam4.70466.

References
1.
Cornely O, Cisneros J, Torre-Cisneros J, Rodriguez-Hernandez M, Tallon-Aguilar L, Calbo E . Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. J Antimicrob Chemother. 2019; 75(3):618-627. PMC: 7021089. DOI: 10.1093/jac/dkz497. View

2.
Gkioni E, Rius R, Dodd S, Gamble C . A systematic review describes models for recruitment prediction at the design stage of a clinical trial. J Clin Epidemiol. 2019; 115:141-149. DOI: 10.1016/j.jclinepi.2019.07.002. View

3.
Mahmud A, Zalay O, Springer A, Arts K, Eisenhauer E . Barriers to participation in clinical trials: a physician survey. Curr Oncol. 2018; 25(2):119-125. PMC: 5927782. DOI: 10.3747/co.25.3857. View

4.
Caldwell P, Hamilton S, Tan A, Craig J . Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med. 2010; 7(11):e1000368. PMC: 2976724. DOI: 10.1371/journal.pmed.1000368. View

5.
Treweek S, Lockhart P, Pitkethly M, Cook J, Kjeldstrom M, Johansen M . Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open. 2013; 3(2). PMC: 3586125. DOI: 10.1136/bmjopen-2012-002360. View